Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visugromab in cancer-associated cachexia
NCT07112196Phase 3Recruiting
- Sponsor
- CatalYm
- Start
- Apr 2026
- Primary completion
- Dec 2029
- Countries
- 14
01
Overview
A Phase 3 trial of visugromab in cancer cachexia, sponsored by CatalYm. Started Apr 2026; status: recruiting.
02
Drugs
visugromab
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT07112196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07112196.